Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
NCT07441850

Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy

Led by Beijing Friendship Hospital · Updated on 2026-03-02

186

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to investigate the effects of a perioperative multimodal rehabilitation program on the incidence of postoperative complications and perioperative clinical indexes including functional capacity, nutritional and psychological status in patients with gastric cancer undergoing neoadjuvant therapy. Besides the investigators also develop a smart phone based digital platform aiming to evaluate its effectiveness in improving patient adherence, compared with the conventional telephone supervision approach. The main questions it aims to answer are: * Can the perioperative multimodal rehabilitation program reduce postoperative complications in patients with gastric cancer undergoing neoadjuvant therapy? * Can the smart phone based digital platform improve patients' adherence compared to traditional telephone supervision? * Can the perioperative multimodal rehabilitation program improve the perioperative clinical indicators of patients with gastric cancer undergoing neoadjuvant therapy, including functional capacity, nutritional status and psychological condition? The investigators will compare the perioperative multimodal rehabilitation program with the standard treatment alone to determine whether this program has the effects mentioned above. Participants will follow the perioperative multimodal rehabilitation program from neoadjuvant therapy through to four weeks after discharge.

CONDITIONS

Official Title

Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged between 18 and 70 years
  • Histologically confirmed resectable adenocarcinoma of the oesophago gastric junction or stomach
  • Referred by a multidisciplinary team for neoadjuvant therapy
  • Able to use a smartphone and willing to comply with regular follow-up assessments
  • Provided written informed consent
Not Eligible

You will not qualify if you...

  • Presence of distant metastasis
  • Severe cardiopulmonary disease or other conditions preventing exercise or walking tests
  • Having other concurrent malignant tumors
  • Suspected recurrent gastric cancer
  • Cognitive, communication, or psychiatric issues preventing study compliance
  • Women who are pregnant, breastfeeding, or planning pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beijing Friendship Hospital, Capital Medical University

Beijing, China

Actively Recruiting

Loading map...

Research Team

Z

Zhi Zheng, Attending surgon

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy | DecenTrialz